This Government Contract opportunity from Department Of Defense was posted on May 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Supply of Sumatriptan Succinate Tablets (100mg)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the manufacture and supply of 100mg Sumatriptan Succinate tablets, packaged in bottles containing 9 tablets each, specifically intended for military and veteran healthcare systems. Issued by the Department of Defense through the Medical Supply Chain Pharmaceutical Facility, this subcontract focuses on ensuring a reliable source of this medication, which is used for the treatment of migraines and related conditions. The contract falls under the NAICS code 325412, which relates to pharmaceutical manufacturing. The solicitation was posted on May 10, 2026, with a response deadline set for May 18, 2026, indicating a short window for submission. The exact location of performance and point of contact details were not specified in the available data. The contract aims to support healthcare treatment capabilities within defense-related medical facilities by providing essential pharmaceutical products in compliance with supply requirements.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
